Australia’s only locally manufactured QIV now TGA approved – August 2, 2016

Australia’s only locally manufactured, quadrivalent seasonal influenza vaccine (QIV) received Therapeutic Goods Administration (TGA) approval on July 15, 2016.  Afluria Quad™, Seqirus’ four-strain, inactivated seasonal influenza vaccine, is indicated for people aged 18 years and older.1 The new quadrivalent vaccine will replace the company’s trivalent vaccine (TIV), Fluvax® for the 2017 flu season.  Manufactured by…

Read More

The future of medicine is not a ‘one-size-fits-all’ – July 8, 2016

Research and Markets, a world-renowned market research report hub, recently released their new Global DNA Sequencing Products Market 2016-2020 report that identified personalised medicine and global DNA sequencing products as the next big trend in medical rese arch. According to the report, DNA sequencing technology can be applied in diagnostics, drug and biomarker discovery, agriculture,…

Read More

Belinda, 40: Forensic scientist, keen cyclist & CIA trial patient recovering from breast cancer, PERTH

The life of happily married forensic scientist and avid cyclist, Belinda, 40, Perth was turned upside down when she received a diagnosis of stage two breast cancer on October 13, 2015. The self-described “stoic, upbeat, positive person” initially noticed a distortion of her left breast in September, 2015 while rehabilitating from a shoulder injury. She…

Read More

Stephanie, 42, Pneumonia takes heavy toll on marketer & mother-of-two, SYDNEY

In July 2013, having just started a new role, then 39-year-old Sydney-based professional marketeer and mother-of-two, Stephanie, took ill. Plagued by a productive cough, fever and overwhelming exhaustion for weeks on end, Stephanie dangerously chose to soldier-on. Until one day, when she pulled up to the curb to collect her children from school, stepped out…

Read More